Inotiv's Shares Fall as It Reports Subpoena in Primate Probe

Shares of medical researcher Inotiv Inc. on Thursday extended a decline that began with unexpected losses and continued after the company disclosed that recently bought unit received a grand jury subpoena from Miami prosecutors investigating imports of primates from Asia.

Inotiv, whose contract laboratories serve major pharmaceutical companies, fell 14% on Thursday, adding to a drop of nearly 17% on Wednesday.